Table 3. Summary of univariate analysis and multivariate analysis of overall survival.

Factor	Total cases (n = 122)
	Univariate analysis		Multivariate analysis
	Risk ratio label (95% confidence interval)	P	Risk ratio label (95% confidence interval)	P
HSF1(pSer326) expression (Score 0~+2)
0	1	-
1	3.56 (1.40–9.04)	0.008**
2	3.57 (1.41–9.08)	0.007**
Advanced age (over 50)	1.78 (0.82–3.87)	0.14
Multipara (≧2)	1.78 (0.70–3.24)	0.12
Histological subtype
Serous	1.55 (0.82–2.92)	0.17
Cleacell	0.81 (0.40–1.63)	0.55
Endometrioid	0.50 (0.16–1.64)	0.26
Mucinous	0.97 (0.23–4.02)	0.97
Advanced Stage (over FIGO Stage III)	8.02 (2.85–22.59)	< 0.001**
Peritoneal dissemination	4.73 (1.93–9.90)	< 0.001**
Lymph node metastasis	1.48 (0.78–2.81)	0.23
Platinum resistant	12.46 (5.18–29.96)	< 0.001**	7.35 (2.72–19.87)	< 0.001**
Optimal debulking surgery	0.14 (0.07–0.30)	< 0.001**	0.40 (0.17–0.94)	0.04*